These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36150213)

  • 1. Care for adults with COVID-19: living guidelines from the National COVID-19 Clinical Evidence Taskforce.
    White H; McDonald SJ; Barber B; Davis J; Burr L; Nair P; Mukherjee S; Tendal B; Elliott J; McGloughlin S; Turner T
    Med J Aust; 2022 Oct; 217(7):368-378. PubMed ID: 36150213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
    Hirsch C; Park YS; Piechotta V; Chai KL; Estcourt LJ; Monsef I; Salomon S; Wood EM; So-Osman C; McQuilten Z; Spinner CD; Malin JJ; Stegemann M; Skoetz N; Kreuzberger N
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD014945. PubMed ID: 35713300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical care of children and adolescents with COVID-19: recommendations from the National COVID-19 Clinical Evidence Taskforce.
    Fraile Navarro D; Tendal B; Tingay D; Vasilunas N; Anderson L; Best J; Burns P; Cheyne S; Craig SS; Erickson SJ; Fancourt NS; Goff Z; Kapuya V; Keyte C; Malyon L; McDonald S; White H; Wurzel D; Bowen AC; McMullan B;
    Med J Aust; 2022 Mar; 216(5):255-263. PubMed ID: 34689329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients.
    Bellino S
    Ann Med; 2022 Dec; 54(1):2856-2860. PubMed ID: 36259490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese rapid/living recommendations on drug management for COVID-19: updated guidelines (July 2022).
    Yamakawa K; Yamamoto R; Terayama T; Hashimoto H; Ishihara T; Ishimaru G; Imura H; Okano H; Narita C; Mayumi T; Yasuda H; Yamada K; Yamada H; Kawasaki T; Shime N; Doi K; Egi M; Ogura H; Aihara M; Kushimoto S; Nishida O;
    Acute Med Surg; 2022; 9(1):e789. PubMed ID: 36267628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A living WHO guideline on drugs for covid-19.
    Agarwal A; Hunt B; Stegemann M; Rochwerg B; Lamontagne F; Siemieniuk RA; Agoritsas T; Askie L; Lytvyn L; Leo YS; Macdonald H; Zeng L; Alhadyan A; Muna A; Amin W; da Silva ARA; Aryal D; Barragan FAJ; Bausch FJ; Burhan E; Calfee CS; Cecconi M; Chacko B; Chanda D; Dat VQ; De Sutter A; Du B; Freedman S; Geduld H; Gee P; Haider M; Gotte M; Harley N; Hashimi M; Hui D; Ismail M; Jehan F; Kabra SK; Kanda S; Kim YJ; Kissoon N; Krishna S; Kuppalli K; Kwizera A; Lado Castro-Rial M; Lisboa T; Lodha R; Mahaka I; Manai H; Mendelson M; Migliori GB; Mino G; Nsutebu E; Peter J; Preller J; Pshenichnaya N; Qadir N; Ranganathan SS; Relan P; Rylance J; Sabzwari S; Sarin R; Shankar-Hari M; Sharland M; Shen Y; Souza JP; Swanstrom R; Tshokey T; Ugarte S; Uyeki T; Evangelina VC; Venkatapuram S; Vuyiseka D; Wijewickrama A; Tran L; Zeraatkar D; Bartoszko JJ; Ge L; Brignardello-Petersen R; Owen A; Guyatt G; Diaz J; Kawano-Dourado L; Jacobs M; Vandvik PO
    BMJ; 2020 Sep; 370():m3379. PubMed ID: 32887691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical care of pregnant and postpartum women with COVID-19: Living recommendations from the National COVID-19 Clinical Evidence Taskforce.
    Vogel JP; Tendal B; Giles M; Whitehead C; Burton W; Chakraborty S; Cheyne S; Downton T; Fraile Navarro D; Gleeson G; Gordon A; Hunt J; Kitschke J; McDonald S; McDonnell N; Middleton P; Millard T; Murano M; Oats J; Tate R; White H; Elliott J; Roach V; Homer CSE;
    Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):840-851. PubMed ID: 33119139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis.
    Siemieniuk RA; Bartoszko JJ; Díaz Martinez JP; Kum E; Qasim A; Zeraatkar D; Izcovich A; Mangala S; Ge L; Han MA; Agoritsas T; Arnold D; Ávila C; Chu DK; Couban R; Cusano E; Darzi AJ; Devji T; Foroutan F; Ghadimi M; Khamis A; Lamontagne F; Loeb M; Miroshnychenko A; Motaghi S; Murthy S; Mustafa RA; Rada G; Rochwerg B; Switzer C; Vandvik PO; Vernooij RW; Wang Y; Yao L; Guyatt GH; Brignardello-Petersen R
    BMJ; 2021 Sep; 374():n2231. PubMed ID: 34556486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The National COVID-19 Clinical Evidence Taskforce: pregnancy and perinatal guidelines.
    Homer CS; Roach V; Cusack L; Giles ML; Whitehead C; Burton W; Downton T; Gleeson G; Gordon A; Hose K; Hunt J; Kitschke J; McDonnell N; Middleton P; Oats JJ; Shand AW; Wilton K; Vogel J; Elliott J; McGloughlin S; McDonald SJ; White H; Cheyne S; Turner T;
    Med J Aust; 2022 Nov; 217 Suppl 9():S14-S19. PubMed ID: 36183307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESCMID COVID-19 living guidelines: drug treatment and clinical management.
    Bartoletti M; Azap O; Barac A; Bussini L; Ergonul O; Krause R; Paño-Pardo JR; Power NR; Sibani M; Szabo BG; Tsiodras S; Verweij PE; Zollner-Schwetz I; Rodríguez-Baño J
    Clin Microbiol Infect; 2022 Feb; 28(2):222-238. PubMed ID: 34823008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
    Schilling WHK; Jittamala P; Watson JA; Boyd S; Luvira V; Siripoon T; Ngamprasertchai T; Batty EM; Cruz C; Callery JJ; Singh S; Saroj M; Kruabkontho V; Ngernseng T; Tanglakmankhong N; Tubprasert J; Abdad MY; Madmanee W; Kouhathong J; Suwannasin K; Pagornrat W; Piaraksa N; Hanboonkunupakarn P; Hanboonkunupakarn B; Poovorawan K; Potaporn M; Srisubat A; Loharjun B; Taylor WRJ; Chotivanich V; Chotivanich K; Imwong M; Pukrittayakamee S; Dondorp AM; Day NPJ; Teixeira MM; Piyaphanee W; Phumratanaprapin W; White NJ;
    Lancet Infect Dis; 2024 Jan; 24(1):36-45. PubMed ID: 37778363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatments for covid-19: living systematic review and network meta-analysis.
    Siemieniuk RA; Bartoszko JJ; Zeraatkar D; Kum E; Qasim A; Martinez JPD; Izcovich A; Lamontagne F; Han MA; Agarwal A; Agoritsas T; Azab M; Bravo G; Chu DK; Couban R; Devji T; Escamilla Z; Foroutan F; Gao Y; Ge L; Ghadimi M; Heels-Ansdell D; Honarmand K; Hou L; Ibrahim Q; Khamis A; Lam B; Mansilla C; Loeb M; Miroshnychenko A; Marcucci M; McLeod SL; Motaghi S; Murthy S; Mustafa RA; Pardo-Hernandez H; Rada G; Rizwan Y; Saadat P; Switzer C; Thabane L; Tomlinson G; Vandvik PO; Vernooij RW; Viteri-García A; Wang Y; Yao L; Zhao Y; Guyatt GH; Brignardello-Petersen R
    BMJ; 2020 Jul; 370():m2980. PubMed ID: 32732190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-American Guidelines for the treatment of SARS-CoV-2/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API).
    Barbosa AN; Chebabo A; Starling C; Pérez C; Cunha CA; de Luna D; Nunes EP; Zambrano G; Ferreira JC; Croda J; Falavigna M; Gomes-da-Silva MM; Thormann M; Cimerman S; Parahiba SM; Tanni S; Bernardo WM; Rodriguez-Morales AJ
    Ann Clin Microbiol Antimicrob; 2023 Aug; 22(1):67. PubMed ID: 37550690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia.
    Falavigna M; Stein C; Amaral JLGD; Azevedo LCP; Belli KC; Colpani V; Cunha CAD; Dal-Pizzol F; Dias MBS; Ferreira JC; Freitas APDR; Gräf DD; Guimarães HP; Lobo SMA; Monteiro JT; Nunes MS; Oliveira MS; Prado CCL; Santos VCC; Silva RMD; Sobreira ML; Veiga VC; Vidal ÁT; Xavier RM; Zavascki AP; Machado FR; Carvalho CRR
    Rev Bras Ter Intensiva; 2022; 34(1):1-12. PubMed ID: 35674525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Holgersson J; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS One; 2021; 16(3):e0248132. PubMed ID: 33705495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.